Abstract:The diterpenoid paclitaxel (Taxol ® ) is a blockbuster anticancer agent that was originally isolated from the Pacific yew ( Taxus brevifolia ) five decades ago. Despite the wealth of information gained over the years on Taxol research, there still remains supply issues to meet increasing clinical demand. Although alternative Taxol production methods have been developed, they still face several drawbacks that cause supply shortages and high production costs. It is highly desired to develop biotechnological production platforms for Taxol, however, there are still gaps in our understanding of the biosynthetic pathway, catalytic enzymes, regulatory and control mechanisms that hamper production of this critical drug by synthetic biology approaches. Over the past 5 years, significant advances were made in metabolic engineering and optimization of the Taxol pathway in different hosts, leading to accumulation of taxane intermediates. Computational and experimental approaches were leveraged to gain mechanistic insights into the catalytic cycle of pathway enzymes and guide rational protein engineering efforts to improve catalytic fitness and substrate/product specificity, especially of the cytochrome P450s (CYP450s). Notable breakthroughs were also realized in engineering the pathway in plant hosts that are more promising in addressing the challenging CYP450 chemistry. Here, we review these recent advances and in addition, we summarize recent transcriptomic data sets of Taxus species and elicited culture cells, and give a bird’s-eye view of the information that can be gleaned from these publicly available resources. Recent mining of transcriptome data sets led to discovery of two putative pathway enzymes, provided many lead candidates for the missing steps and provided new insights on the regulatory mechanisms governing Taxol biosynthesis. All these inferences are relevant to future biotechnological production of Taxol.

Synthesis of Taxol and Docetaxel by Using 10‐Deacetyl‐7‐xylosyltaxanes

[The Extraction and Separation of an Active and Available Component from Taxus Mairei].

An Efficient Conversion Method of 10-Deacetyl-7-epi-taxol into Taxol

Synthesis of Paclitaxel Side Chain Via Multi-Component Reaction and Its Application to the Synthesis of Paclitaxel Analogues

Asymmetric Total Synthesis of Taxol

Biosynthesis of the highly oxygenated tetracyclic core skeleton of Taxol

Biochemical synthesis of taxanes from mevalonate

Isolation of Taxol,7-Epi-10-deacety Taxol,cephalomannine and the Isomerization of Taxol from 7-Epi-taxol

Conversion of Taxane Glycosides to 10-Deacetylbaccatin III

Recent Research Progress in Taxol Biosynthetic Pathway and Acylation Reactions Mediated by Taxus Acyltransferases

Combined Biotransformations of 4(20),11-Taxadienes

Recent Advances in Metabolic Engineering, Protein Engineering, and Transcriptome-Guided Insights Toward Synthetic Production of Taxol

Technological Improvement of the Semisynthesis of Taxol

Separation and purification of two taxanes and one xylosyl-containing taxane from Taxus wallichiana Zucc.: A comparison between high-speed countercurrent chromatography and reversed-phase flash chromatography.

Synthesis of 7,9-Dideoxybaccatin Iv Analogs from Sinenxan A

Diverse strategic approaches en route to Taxol total synthesis

Strategies and Lessons Learned from Total Synthesis of Taxol

An asymmetric catalytic multi-component reaction enabled the green synthesis of isoserine derivatives and semi-synthesis of paclitaxel

Taxol: biosynthesis, molecular genetics, and biotechnological applications

Uncovering the Baccatin III Biosynthetic Pathway for Sustainable Taxoid Supply

Entry into Major Groups Retaining Taxol Via Sinenxan A